Started in SINTEF in 2013, and participated and lead projects within a broad field of applications: development of cellular models for screening - including advanced 3D-models; biopharmaceutical process development; process development and assays related to immunotherapy - including cellular therapies; and proteomics on microorganisms, biomass, virus, host responses, disease models, endometriosis. Has a strategic focus on contributing towards development of Norwegian health industry.
Education
Master of Technology in Industrial chemistry and biotechnology from NTNU, 2008
PhD in Biomedicine from University of Bergen, 2013
Competence and research areas
Cell culture; primary cells; tissue microenvironment; tumor biology; advanced cell models; extracellular vesicles; bioprocess development; immunotherapy; endometriosis; proteomics; high-throughput screening; biopharmaceuticals.
Linkedin
https://www.linkedin.com/in/hanne-haslene-hox-3b3aa21/
ORCID
https://orcid.org/0000-0001-7298-7332
